---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-014166"
form_type: "8-K"
ticker: "AIMD"
cik: "0001014763"
company_name: "Ainos, Inc."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T04:33:54.782643+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ainos Q3 2023 revenue drops 98.6% to $24.5K; net loss narrows to $3.0M

## Summary
- Revenue fell to $24,489 from $1,757,774 in Q3 2022 due to COVID-19 test kit demand decline.
- Gross profit turned negative ($63,384) vs positive $581,742 YoY on lower sales and inventory loss.
- Net loss narrowed to $2.97M from $7.82M YoY, helped by lower operating expenses.
- Cash and equivalents $2.37M as of Sept 30, 2023; company secured $3M of planned $10M private placement.
- VELDONA Pet launched in Taiwan (300k units shipped); FDA orphan drug designation for VELDONA for oral warts.

## SEC filing metadata
- accession: 0001654954-23-014166
- form_type: 8-K
- ticker: AIMD
- cik: 0001014763
- company_name: Ainos, Inc.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1014763/000165495423014166/0001654954-23-014166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1014763/000165495423014166/aimd_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-014166
- JSON: https://secwatch.observer/filing/0001654954-23-014166.json
- Plain text: https://secwatch.observer/filing/0001654954-23-014166.txt

## Key facts
- Earnings Releases
  Ainos, Inc. reported third quarter ended September 30, 2023 results: revenue US$24,489, net income US$2,975,846.
  - Period: third quarter ended September 30, 2023
  - Revenue: US$24,489
  - Net income: US$2,975,846
  - Result: reported results
  source text: Revenues were US$24,489 in the third quarter of 2023, compared to US$1,757,774 in the same period of 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1014763/000165495423014166/0001654954-23-014166-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.